Cargando…
Improving skeletal muscle insulin sensitivity via beta(2)‐agonist administration: a promising strategy to counteract metabolic disease and muscle loss
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9321888/ https://www.ncbi.nlm.nih.gov/pubmed/35415892 http://dx.doi.org/10.1113/JP282992 |
| _version_ | 1784756159028133888 |
|---|---|
| author | Dirks, Marlou L. |
| author_facet | Dirks, Marlou L. |
| author_sort | Dirks, Marlou L. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9321888 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | John Wiley and Sons Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-93218882022-07-30 Improving skeletal muscle insulin sensitivity via beta(2)‐agonist administration: a promising strategy to counteract metabolic disease and muscle loss Dirks, Marlou L. J Physiol Perspectives John Wiley and Sons Inc. 2022-04-21 2022-05-15 /pmc/articles/PMC9321888/ /pubmed/35415892 http://dx.doi.org/10.1113/JP282992 Text en © 2022 The Authors. The Journal of Physiology published by John Wiley & Sons Ltd on behalf of The Physiological Society. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Perspectives Dirks, Marlou L. Improving skeletal muscle insulin sensitivity via beta(2)‐agonist administration: a promising strategy to counteract metabolic disease and muscle loss |
| title | Improving skeletal muscle insulin sensitivity via beta(2)‐agonist administration: a promising strategy to counteract metabolic disease and muscle loss |
| title_full | Improving skeletal muscle insulin sensitivity via beta(2)‐agonist administration: a promising strategy to counteract metabolic disease and muscle loss |
| title_fullStr | Improving skeletal muscle insulin sensitivity via beta(2)‐agonist administration: a promising strategy to counteract metabolic disease and muscle loss |
| title_full_unstemmed | Improving skeletal muscle insulin sensitivity via beta(2)‐agonist administration: a promising strategy to counteract metabolic disease and muscle loss |
| title_short | Improving skeletal muscle insulin sensitivity via beta(2)‐agonist administration: a promising strategy to counteract metabolic disease and muscle loss |
| title_sort | improving skeletal muscle insulin sensitivity via beta(2)‐agonist administration: a promising strategy to counteract metabolic disease and muscle loss |
| topic | Perspectives |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9321888/ https://www.ncbi.nlm.nih.gov/pubmed/35415892 http://dx.doi.org/10.1113/JP282992 |
| work_keys_str_mv | AT dirksmarloul improvingskeletalmuscleinsulinsensitivityviabeta2agonistadministrationapromisingstrategytocounteractmetabolicdiseaseandmuscleloss |